Clinical Trials Logo
  1. Home
  2. Proton Pump Inhibitor
  3. NCT03467893

Evaluation of Rebound Effect After Withdrawal of Proton Pump Inhibitor in Geriatric Population

Proton Pump Inhibitor Clinical Trial

Official title:
Evaluation of Rebound Effect After Withdrawal of Proton Pump Inhibitor After 8 Weeks of Treatment in Geriatric Population

Clinical Trial Summary

Proton pump inhibitor are frequently used and are short term well tolerated ; but few studies show there are adverse event in long term prescription like fracture or pulmonary infection to Clostridum difficile. The fact is that multi medication in old patient increase the iatrogenic risk and decrease the medication compliance. The Proton pump inhibitor (PPI)are overused in this patient category.Several studies suggest the existence of a rebound effect when people were treated more than 8 weeks ; this effect seems to appear around 14 days after with hyperacidity symptoms.

But there are no studies about old patient. So in this context the aim of the study is to evaluate the prevalence of rebound effect occurence after the end of PPI 8 weeks treatment.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03467893
Study type Observational
Source Groupe Hospitalier Paris Saint Joseph
Contact
Status Completed
Phase
Start date June 10, 2017
Completion date February 28, 2018
View Details
See also
  Status Clinical Trial Phase
Withdrawn NCT03038009 - Proton Pump Inhibitor Prevent Dual Antiplatelet Agents Induced Gastrointestinal Ulcer After Coronary Artery Bypass Graft Phase 4
Completed NCT04637750 - Proton Pump Inhibitors (PPI): a Study to Improve Appropriate Prescriptions in the Elderly N/A
Active, not recruiting NCT05647278 - A RCT of the Efficacy of Tegoprazan 50mg QD in the Treatment of Helicobacter Pylori Infection ( TATH-1 ) Phase 4
Completed NCT05348252 - Patient Journey Application for Discontinuing Inappropriate PPI Use: a Randomized Controlled Trial N/A
Recruiting NCT05590286 - A RCT of the Efficacy of Vonoprazan 20mg QD in the Treatment of Helicobacter Pylori Infection Phase 4
Completed NCT03980899 - Evaluation of the Long-term Tolerance of Proton Pump Inhibitor (PPI) Discontinuation in Geriatric Patients Treated With Long-term Therapy Without a Recognized Indication
Completed NCT05533619 - Risk Factors and Machine Learning Model for Proton Pump Inhibitor Related Acute Kidney Injury
Completed NCT03079050 - An Open-Label Trial of Dexlansoprazole 60mg for the Relief of Heartburn During the Fasting Month of Ramadan Phase 4
Completed NCT02718261 - Sup-Icu RENal (SIREN) Phase 4
Completed NCT04329000 - On-demand PPI Therapy is Effective on Controlling Symptoms in Patients With Barrett's Esophagus. N/A
Recruiting NCT03098537 - Effects of Enteral Nutrition on Stress Ulcer Hemorrage. Multicenter Randomized Controlled Trial N/A